Diagnosis and management of early lung cancer

Surgical Clinics of North America

Volumn 82, Issue 3, 2002, Pages 457-476

  Park, Bernard J ^a   Altorki, Nasser K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER MORTALITY; CANCER STAGING; CAUSE OF DEATH; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; METASTASIS; PRIORITY JOURNAL; REVIEW; SURGICAL APPROACH; THORAX RADIOGRAPHY; UNITED STATES;

EID: 0036620245     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(02)00018-X     Document Type: Article

References (109)

1. Boring CC, Squires TS, Tong T. Cancer statistics 1993. CA Cancer J Clin 1993;43:7-26.
2. Nesbitt JC, Putnam JB, Walsh GL, et al. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995;60:466-72.
3. Eddy DM. Screening for lung cancer. Ann Int Med 1989;111:232-7.
4. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: the Mayo program. J Occup Med 1986;28:746-50.
5. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer: a critique of the Mayo Lung Project. Cancer 1991;67:1155-64.
6. Kubik A, Parkin DM, Khlat M, et al. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990;45:26-33.
7. Melamed MR, Flehinger BJ, Zaman MB, et al. Screening for lung cancer: results of the Memorial Sloan-Kettering study in New York. Chest 1984;86:44-53.
8. Tockman MS. Survival and mortality from lung cancer in a screened population. The Johns Hopkins Study. Chest 1986;89:324-5S.
9. Henschke CI, McCauley D, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99.
10. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225-33.
11. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
12. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primaries in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
13. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-7.
14. Shimizu J, Watanabe Y, Oda M, et al. Results of surgical treatment of stage I lung cancer. Nippon Geka Gakkai Zasshi 1993;94:505-10.
15. Williams DE, Pairolero PC, Danis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981;82:70-6.
16. Friese G, Gabler A, Leibig S. Bronchial carcinoma and long-term survival. Retrospective study of 433 patients who underwent resection. Thorax 1978;33:228-34.
17. Ishida T, Yano T, Maeda K, et al. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 1990;50:708-13.
18. Read RC, Yoder G, Schaeffer RC. Survival after conservative resection for T1N0M0 non-small cell lung cancer. Ann Thorac Surg 1990;49:391-8.
19. Soorae AD, Abbey-Smith R. Tumor size as a prognostic factor after resection of lung carcinoma. Thorax 1977;32:19-25.
20. Treasure T, Belcher JR. Prognosis of peripheral lung tumors related to size of the primary. Thorax 1981;36:5-8.
21. Rigler LG. The earliest roentgenographic signs of carcinoma of the lung. JAMA 1966;195:655-7.
22. Geddes DM. The natural history of lung cancer: a review board on rates of tumor growth. Br J Dis Chest 1979;73:1-7.
23. Melamad MR. Lung cancer screening results in the National Cancer Institute New York study. Cancer 2000;89:2356-62.
24. Gasparini S. Bronchoscopic biopsy techniques in the diagnosis and staging of lung cancer. Monaldi Arch Chest Dis 1997;52:392-8.
25. Shure D. Fiberoptic bronchoscopy - diagnostic applications. Clin Chest Med 1987;8:1-13.
26. Woolner LB. Pathology of cancer detected cytologically. In: Atlas of early lung cancer. National Cancer Institute, National Institute of Health, U.S. Department of Health and Human Services; 1983. Tokyo: Igaku-Shoin: p. 107-213.
27. Bechtel JJ, Kelly WR, Petty TL, et al. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program. Arch Intern Med 1994;154:975-80.
28. Cortese DA, Pairolero PC, Bergstralh EJ, et al. Roentgenographically occult lung cancer: a 10-year experience. J Thorac Cardiovasc Surg 1983;86:373-80.
29. Hung J, Lam S, LeRiche JC, et al. Autofluorescence of normal and malignant bronchial tissue. Laser Surg Med 1991;11:99-105.
30. Kennedy TC, Lam S, Hirsch FR. Review of recent advances in fluorescence bronchoscopy in early localization of central airway lung cancer. Oncologist 2001;6:257-62.
31. Hirsch FR, Prindiville SA, Miller YE, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 2001;93:1385-91.
32. Lam S, Kennedy TC, Unger M, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998;113:696-702.
33. Lam S, MacAulay C, leRiche JC, et al. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 2000;89:2468-73.
34. Venmans BJ, van der Linden JC, van Boxem AJ, et al. Early detection of pre-invasive lesions in high risk patients. A comparison of conventional fiberoptic and fluorescence bronchoscopy. J Bronchology 1998;5:280-3.
35. Yankelevitz DF, Reeves AP, Kostis WJ, et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;217:251-6.
36. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319-23.
37. Staples CA, Muller NL, Miller RR, et al. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 1988;167:367-72.
38. Gupta NC, Graeber GM, Rogers JS, et al. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. Ann Surg 1999;229:286-91.
39. Pieterman RM, van Putten JWG, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254-61.
40. Protopapas Z, White CS, Miller BH, et al. Transthoracic needle biopsy practices: results of a nationwide survey [abstract]. Radiology 1996;201(P):270-1.
41. Pinstein ML, Scott RL, Salazar J. Avoidance of negative percutaneous lung biopsy using contrast-enhanced CT. AJR Am J Roentgenol 1983;140:265-7.
42. Moore EH, Shepard JO, McLoud TC, et al. Positional precautions in needle aspiration lung biopsy. Radiology 1990;175:733-5.
43. Permutt LM, Johnson WW, Dunnick NR. Percutaneous transthoracic needle aspiration: a review. AJR Am J Roentgenol 1989;152:451-5.
44. Fish GD, Stanley JH, Miller KS, et al. Post-biopsy pneumothorax: estimating the risk by chest radiography and pulmonary function tests. AJR Am J Roentgenol 1988;150:714.
45. Moore EA. Technical aspects of needle aspiration lung biopsy: a personal perspective. Radiology 1998;208:303-18.
46. Wescott JL. Percutaneous transthoracic needle biopsy. Radiology 1988;169:593-601.
47. Charig MJ, Stutley JE, Padley SPG, et al. The value of negative needle biopsy in suspected operable lung cancer. Clin Radiol 1991;44:147-9.
48. Calhoun P, Feldman PS, Armstrong P, et al. The clinical outcome of needle aspiration of the lung when cancer is not diagnosed. Ann Thorac Surg 1986;41:592-6.
49. Carlens EJ. Mediastinoscopy: a method for inspection and tissue biopsy in the superior mediastinum. Dis Chest 1959;36:343-52.
50. Gdeedo A, Van Schill P, Corthouts B, et al. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J 1997;10:1547-51.
51. Luke WP, Pearson FG, Todd TPU, et al. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg 1989;91:53-6.
52. Hammoud ZT, Anderson RC, Meyers BF, et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999;118:894-9.
53. Patterson GA, Piazza D, Pearson FG, et al. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg 1987;43:155-9.
54. Ginsberg RJ, Rice TW, Goldberg, et al. Extended cervical mediastinoscopy: a single staging procedure for bronchogenic carcinoma of the left upper lobe. J Thorac Cardiovasc Surg 1987;94:673-8.
55. McNeill T, Chamberlain J. Diagnostic anterior mediastinotomy. Ann Thorac Surg 1966;2:532-9.
56. Olak J. Parasternal mediastinotomy (Chamberlain procedure). Chest Surg Clin North Am 1993;6:31-9.
57. Jolly PC, Li W, Anderson RP. Anterior and cervical mediastinoscopy for determining operability and predicting resectability in lung cancer. J Thorac Cardiovasc Surg 1980;79:366-71.
58. Mentzer SJ, Swanson SJ, Decamp MM, et al. Mediastinoscopy, thoracoscopy and video-assisted thoracic surgery in the diagnosis of lung cancer. Chest 1997;112:239S-41S.
59. Van Schil P, Van Den Brande F. The current role of invasive staging of lung cancer. Monaldi Arch Chest Dis 1997;52:237-41.
60. Hazelrigg SR, Nunchuck SK, LoCicero J III, et al. Video-assisted thoracic surgery study group data. Ann Thorac Surg 1993;56:1039-44.
61. Nomori H, Horio H, Fuyuno G, et al. Lung adenocarcinomas diagnosed by open lung or thoracoscopic vs. bronchoscopic biopsy. Chest 1998;114:40-4.
62. Landreneau RJ, Hazelrigg SR, Mack MJ, et al. Thoracoscopic mediastinal lymph node sampling: useful for mediastinal lymph node stations inaccessible by cervical mediastinoscopy. J Thorac Cardiovasc Surg 1993;106:554-8.
63. Rendina EA, Venura F, DeGiaconio T, et al. Comparative merits of thoracoscopy, mediastinoscopy, and mediastinotomy for mediastinal biopsy. Ann Thorac Surg 1994;57:992-5.
64. Solanini L, Bagioni P, Campanini A, et al. Diagnostic role of videothoracoscopy in mediastinal disease. Eur J Cardiothorac Surg 1998;13:491-3.
65. Jensik RJ, Faber LP, Milloy FJ, et al. Segmental resection for lung cancer - a fifteen-year experience. J Thorac Cardiovasc Surg 1973;66:563-72.
66. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. J Thorac Cardiovasc Surg 1994;107:1087-94.
67. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-23.
68. Kodama K, Doi O, Higashiyama M, et al. Intentional limited resection for selected patients with T1 N0 M0 non-small cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg 1997;114:347-53.
69. Okada M, Yoshikawa K, Hatta T, et al. Is segmentectomy with lymph node assessment an laternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 2001;71:956-61.
70. Assamura H, Nakayama H, Kondo H, et al. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg 1996;111:1125-34.
71. Graham AN, Chan KJ, Pastorino U, et al. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 1999;117:246-51.
72. Naruke T. Significance of lymph node metastases in lung cancer. Semin Thorac Cardiovasc Surg 1993;5:210-8.
73. Oda M, Watanabe Y, Shimizu J, et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer 1998;22:23-30.
74. Izbicki JR, Thetter O, Habekost M, et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 1994;81:229-35.
75. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg 1998;22:290-5.
76. Naruke T, Suemasu K, Ischikawa S. Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. J Thorac Cardiovasc Surg 1976;71:279-85.
77. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1047-9.
78. Lewis R, Caccavale RJ, Sisler GE, et al. One hundred consecutive patients undergoing video-assisted thoracic operations. Ann Thorac Surg 1992;54:421-6.
79. Giudicelli R, Thomas P, Lonjon T, et al. Video-assisted minithoracotomy versus muscle-sparing thoracotomy for performing lobectomy. Ann Thorac Surg 1994;58:712-8.
80. Kirby TJ, Rice TW. Thoracoscopic lobectomy. Ann Thorac Surg 1993;56:784-6.
81. Lewis RJ. The role of video-assisted thoracic surgery for carcinoma of the lung: wedge resection to lobectomy by simultaneous individual stapling. Ann Thorac Surg 1993;56:762-8.
82. Lewis RJ, Caccavale RJ, Sisler GE, et al. One hundred video-assisted thoracic surgical simultaneously stapled lobectomies without rib spreading. Ann Thorac Surg 1997;63:1415-22.
83. McKenna RJ Jr. Lobectomy by video-assisted thoracic surgery with mediastinal node sampling for lung cancer. J Thorac Cardiovasc Surg 1994;107:879-82.
84. Roviaro G, Varoli F, Rebuffat C, et al. Videothoracoscopic staging and treatment of lung cancer. Ann Thorac Surg 1995;59:971-4.
85. Nakata M, Saeki H, Yokoyama N, et al. Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg 2000;70:938-41.
86. Kirby TJ, Mack MJ, Landreneau RJ, et al. Lobectomy-video-assisted thoracic surgery versus muscle-sparing thoracotomy: a randomized trial. J Thorac Cardiovasc Surg 1995;109:997-1002.
87. The Japan Lung Cancer Society. Classification of lung cancer. Tokyo: Kanehara; 2000. p. 34-5.
88. Hayata Y Kato H, Konaka C, et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982;81:269-77.
89. Lam S. Photodynamic therapy of lung cancer. Sem Onc 1994;21(6)(Suppl 15):15-19.
90. Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study of photodynamic therapy with Photofrin II for centrally located early-stage lung cancer. J Clin Oncol 1993;11:1852-7.
91. Woolner LB, Fontana RS, Cortese DA, et al. Roentgenographically occult lung cancer: Pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 1984;59:453-66.
92. Kato H. Photodynamic therapy for lung cancer-A review of 19 years' experience. J Photochem Photobiol B 1998;42:96-9.
93. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997;72:595-602.
94. Feld R, Rubinstein L, Thomas PA, et al. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. J Natl Cancer Inst 1993;85:299-306.
95. Niiranen A, Niitamokorhonen S, Kouri M, et al. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: A randomized study. J Clin Oncol 1992;10:1927-32.
96. Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol 1996;14:1045-7.
97. Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA non-small cell lung cancer: A 7-year assessment of a randomized controlled trial. Lung Cancer 1999;26:7-14.
98. Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. Lung Cancer 1998;21:1-6.
99. Pisters KM, Ginsberg RJ, Giroux DJ, et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. J Thorac Cardiovasc Surg 2000;119:429-39.
100. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. J Thorac Cardiovasc Surg 1994;107:1087-94.
101. Thomas PA, Jr, Rubinstein L. Malignant disease appearing late after operation for T1N0 non-small-cell lung cancer. The Lung Cancer Study Group. J Thorac Cardiovasc Surg 1993;106:1053-8.
102. Ichinose Y, Hara N, Ohta M, et al. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? J Thorac Cardiovasc Surg 1993;106:90-4.
103. Maruyama R, Sugio K, Mitsudomi T, et al. Relationship between early recurrence and micrometastases in lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997;114:535-43.
104. Ohgami A, Mitsudomi T, Sugio K, et al. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann Thorac Surg 1997;64:363-7.
105. Passlick B, Kubuschok B, Izbicki JR, et al. Isolated tumor cells in bone marrow predict reduced survival in none-negative non-small cell lung cancer. Ann Thorac Surg 1999;68:2053-8.
106. Suzuki K, Nagai K, Yoshida J, et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999;67:927-32.
107. Slebos RJC, Kibbelaar RE, Daleso O, et al. K-ras oncogene product in NSCLC. N Engl J Med 1990;323:561-5.
108. Pennzella F, Turkey H, Kuzu I, et al. bcl-2 protein in NSCLC. N Engl J Med 1994;329:690-4.
109. Horio Y, Tamakawa K, Nakamura Y, et al. Prognostic significance of p53 mutations and 3p deletions in primary resected NSCLC. Cancer Res 1993;53:1-4.